Clinical Trials Browser

Withdrawn × Kidney Neoplasms × Interleukin-2 × Clear all

NCT01355562 2020-04-30

Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer

Phase 2 Withdrawn

DermatologicGenitourinary

Kidney Neoplasms, Melanoma